anthranilic acid has been researched along with Osteoporosis in 1 studies
anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Excerpt | Relevance | Reference |
---|---|---|
"Kynurenines were analysed by HPLC." | 5.33 | Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. ( Darlington, LG; Forrest, CM; Mackay, GM; Oxford, L; Stone, TW; Stoy, N, 2006) |
"Kynurenines were analysed by HPLC." | 1.33 | Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. ( Darlington, LG; Forrest, CM; Mackay, GM; Oxford, L; Stone, TW; Stoy, N, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forrest, CM | 1 |
Mackay, GM | 1 |
Oxford, L | 1 |
Stoy, N | 1 |
Stone, TW | 1 |
Darlington, LG | 1 |
1 other study available for anthranilic acid and Osteoporosis
Article | Year |
---|---|
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
Topics: 3-Hydroxyanthranilic Acid; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Indomethac | 2006 |